NR4A2 and Parkinson disease: Repression of iNos was probably the result of direct competition between Nurr1 and NFκB on the iNos promoter, as indicated by ChIP-qPCR assay, in agreement with the mechanism of action proposed by Sajio and coworkers for PD (Saijo et al., 2009).